Germany's t2cure gets first EU advanced therapy certificate
This article was originally published in Scrip
Executive Summary
A somatic cell therapy for treating cardiovascular diseases has become the first product to obtain certification of experimental data by the European Medicines Agency under the EU's advanced therapies framework.